AMAG
AMAG Pharmaceuticals
AMAG
AMAG
Delisted
AMAG was delisted on the 13th of November, 2020.
170 hedge funds and large institutions have $526M invested in AMAG Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 64 increasing their positions, 59 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
55% less call options, than puts
Call options by funds: $3.7M | Put options by funds: $8.28M
Holders
170
Holding in Top 10
1
Calls
$3.7M
Puts
$8.28M
Top Buyers
| 1 | +$6.63M | |
| 2 | +$6.38M | |
| 3 | +$4.4M | |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$4.35M |
| 5 |
BlackRock
New York
|
+$2.65M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$5.88M | |
| 3 | -$5.41M | |
| 4 |
Goldman Sachs
New York
|
-$5.3M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$5.28M |